Table 1.
Results of primary screening.
Substrates | Number of positive clones – Hit rate |
X-β-D-GalNac | 47 – 2,3‰ |
X-β-D-GlcNac | 67 – 3,3‰ |
X-α-D-Man | 2 – 0,1‰ |
X-α-D-Neu5Ac | 27 – 1,3‰ |
X-β-D-Man | 17 – 0,8‰ |
X-α-L-Fuc | 0 |
Single activities | Number of positive clones |
X-β-D-GalNac | 15 |
X-β-D-GlcNac | 29 |
X-α-D-Man | 1 |
X-α-D-Neu5Ac | 20 |
X-β-D-Man | 9 |
Multiple activities | Number of positive clones |
X-β-D-Man + X-α-D-Neu5Ac | 2 |
X-β-D-GlcNac + X-α-D-Neu5Ac | 1 |
X-β-D-GlcNac + X-β-D-Man | 2 |
X-β-D-GlcNac + X-β-D-GalNac | 27 |
X-β-D-GlcNac + X-α-D-Man | 1 |
X-β-D-GlcNac + X-β-D-GalNac + X-β-D-Man | 1 |
X-β-D-GlcNac + X-β-D-GalNac + X-α-D-Neu5Ac | 3 |
X-β-D-GlcNac + X-α-D-Man+ X-β-D-Man | 2 |
X-β-D-GlcNac + X-β-D-GalNac + X-α-D-Neu5Ac + X- β-D-Man | 1 |